Skip to main content

Lyrebird Health

Category: AI in Healthcare

An AI medical scribe that automates clinical documentation by recording, transcribing, and summarizing patient-doctor conversations directly into electronic medical records. Lyrebird Health was founded in 2023. The company is led by Kai Van Lieshout. Based in Melbourne, Australia. Team size: 45. Total funding raised: $12 million. Latest round: $12 million Venture Round (Pre-Seed - Sep 15, 2023). Key investors include Five V Capital, Octopus Ventures, Startmate.

Founded
2023
Headquarters
Melbourne, Australia
Team size
45
Total funding
$12 million

Value proposition

To reduce the administrative burden on clinicians, saving them 6-8 minutes per consultation and over two hours of documentation time per day, thus reducing burnout and allowing them to focus on patient care.

Products and solutions

Lyrebird Scribe

Unique value

The platform is co-designed with clinicians and offers deep integration with major Australian Electronic Medical Record (EMR) systems, making it a seamless part of the existing workflow.

Target customer

Medical practitioners including General Practitioners (GPs), Specialists, and Allied Health professionals.

Industries served

Healthcare

Technology advantage

Full integration with market-leading Australian EMR systems like Best Practice and Gentu. The platform is compliant with Australian privacy laws and Therapeutic Goods Administration (TGA) regulations.

How they differentiate

Lyrebird differentiates through its deep EMR integrations within the Australian market, a strong focus on co-design with local clinicians, and adherence to Australian healthcare data privacy and security standards.

Main competitors

Heidi Health, DeepScribe, Suki

Key partnerships

Best Practice Software, Alder Hey Children's NHS Foundation Trust (UK), Gold Coast Hospital and Health Service, Cubiko, HealthShare (Better Consult), Ochre Health, King's Hospital Dubai, South West London NHS Acute Provider Collaborative (4 trusts)

Notable customers

Gold Coast Hospital and Health Service, Alder Hey Children's NHS Foundation Trust, South West London NHS Acute Provider Collaborative (St George's, Epsom and St Helier, Croydon Health Services, Kingston and Richmond NHS Foundation Trusts) — deploying to up to 20, 000 clinicians

Major milestones

Secured $12 million for global expansion (Jun 2025)., Launched in 2023 and established partnerships with major EMR providers., Expanded into the UK market with a partnership with Alder Hey Children's NHS Foundation Trust., Partnered with Cubiko for integrated care prompts (Jun 2025)., Partnered with HealthShare/BetterConsult for pre-consult patient consent (May 2025)., Partnered with Ochre Health (Jun 2025)., Secured the UK's largest ambient AI deployment — four South West London NHS Trusts deploying to 20,000 clinicians (Apr 2026)., Appointed Dr. Ray Boyapati as Chief Clinical Officer (May 2026).

Growth metrics

Saves clinicians 6-8 minutes per consultation; Over 99% of patients consent to their appointments being recorded.

Market positioning

A leading provider of AI medical scribe technology in Australia, positioning itself as a clinician-centric solution that is deeply embedded in the primary care workflow.

Geographic focus

Initially Australia, with active expansion into the United Kingdom and planned expansion into the Middle East.

Patents and IP

Not publicly available

About Kai Van Lieshout

Kai Van Lieshout is the Co-Founder and CEO of Lyrebird Health. He co-founded the company in 2023 after a personal experience with the healthcare system highlighted the administrative burden placed on doctors. His vision for Lyrebird Health is to give doctors more time to focus on patient care by automating clinical documentation through AI. Before Lyrebird Health, Kai gained experience at companies like Tesla, Pathzero, and OpenGrid, and also has a background connected to St Vincent's Hospital Melbourne. He holds a degree from the University of Melbourne.

Official website: